Ligand · 216
216 · [4-R-(4-alpha,6-beta,7-beta]-hexahydro-5,6-di(hydroxy)-1,3-di(allyl)-4,7-bisphenylmethyl)-2H-1,3-diazepinone
216, [4-R-(4-alpha,6-beta,7-beta]-hexahydro-5,6-di(hydroxy)-1,3-di(allyl)-4,7-bisphenylmethyl)-2H-1,3-diazepinone (C25 H30 N2 O3, 406.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 216
- Formula
- C25 H30 N2 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
216 in 2 structures; the first of them:
- 1HWR · Molecular recognition of cyclic urea HIV protease inhibitors · 216 B216 · binds LEU23, ASP25, GLY27, ALA28, ILE47, GLY48, GLY49, ILE50 and 14 more
- 1HWR · Molecular recognition of cyclic urea HIV protease inhibitors · 216 B216 · binds LEU23, ASP25, GLY27, ALA28, ILE47, GLY48, GLY49, ILE50 and 14 more
Residues it binds most
GLY 2, ILE 2, ALA 2, ASP 2, LEU 2, PRO 2, VAL 2, ARG 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.